Biologics Outsourcing Market Size, Share, Growth Report 2030

Biologics Outsourcing Market

Biologics Outsourcing Market By Type (Antibodies, Monoclonal Antibodies, Antibody Drug Conjugates, Others, Recombinant Proteins, Vaccines, Others), By Source (Human, Microbial, Others), By Application (Stem Cell Research, Vaccine Development, Tissue Related Products development, Others), and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028

Category: Pharmaceutical Report Format : PDF Pages: 130 Report Code: ZMR-2577 Published Date: May-2022 Status : Published

Biologics Outsourcing Market Analysis, Trends and Forecast Biologics Outsourcing Market Industry Overview, Market Growth, Syndicate Report

Biologics Outsourcing Market: Industry Prospective

The global Biologics Outsourcing market was worth around USD 11,285.4 million in 2021 and is estimated to grow to about USD 23620.6 million by 2028, with a compound annual growth rate (CAGR) of approximately 13.1 percent over the forecast period. The report analyzes the Biologics Outsourcing market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the Biologics Outsourcing market.

Biologics Outsourcing Market: Overview

Biologics Outsourcing services are expected to see a massive increase in popularity over the forecast period owing to rising investments in biotechnology research and development activities across the world. Biologics are drugs that are directly procured from living organisms and are extensively used in the treatment of multiple chronic diseases across the world.

These drugs are seeing a substantial increase in demand and are expected to be highly popular over the forecast period. They are also seeing an increase in use for the treatment of cardiovascular diseases which have massively increased in incidence over the past few years.

Biologics Outsourcing companies are expected to see good growth in business and revenue over the forecast period as the advancements in the healthcare sector boost. An increasing geriatric population is also expected to boost the market for Biologics Outsourcing over the forecast period.

Global Biologics Outsourcing MarketRequest Free Sample

COVID-19 Impact:

The COVID-19 pandemic had a significantly adverse impact on the Biologics Outsourcing market. The Biologics Outsourcing services saw a drop in demand owing to changing world landscape under the lockdown restrictions that were imposed across the world to contain the spread of infections. However, the Biologics Outsourcing market did also experience some increase in demand as multiple vaccine development programs were outsourced to small biotechnology companies and hence kept the Biologics Outsourcing market afloat during the pandemic.

The Biologics Outsourcing market is anticipated to rise at its full potential over the forecast period from the post-pandemic era as the lockdown restrictions are lifted and the world returns to normal. The Biologics Outsourcing market will see a high influx of investments in the research and development sector and hence drive the Biologics Outsourcing growth through 2028.

Biologics Outsourcing Market: Growth Drivers

Increasing Focus on Healthcare to Boost growth

Advancements in the healthcare industry have been prevalent across the world and this trend is expected to majorly boost the Biologics Outsourcing market potential over the forecast period. The Biologics Outsourcing market is also expected to be driven by the increasing prevalence of chronic diseases and rising instances of cancers, cardiovascular diseases, etc. increasing geriatric population across the world will also favor the Biologics Outsourcing market potential through 2028. Rising spending on research and development activities by healthcare companies and governments as well are expected to boost the Biologics Outsourcing market potential over the forecast period.

Global Biologics Outsourcing MarketRequest Free Sample

Global Biologics Outsourcing Market: Segmentation

The global Biologics Outsourcing market is segregated based on type, source, application, and region.

By type, the market is divided into Antibodies, Monoclonal Antibodies, Antibody Drug Conjugates, Others, Recombinant Proteins, Vaccines, and Others. The vaccine segment is anticipated to see high growth over the forecast period owing to the rising demand for vaccines for multiple diseases.

By Application, the Biologics Outsourcing market is segmented into Stem Cell Research, Vaccine Development, Tissue Related Products development, and Others. The stem cell research and vaccine development segments are projected to see high demand over the forecast period owing to rising investments in this sector by multiple healthcare companies and governments.

Report Scope:

 

Recent Developments

  • In 2019 – Bristol Meyers Squibb a leading name in the healthcare industry announced an investment of USD 900 million in its research and development division to advance research capabilities for multiple factors such as biologics as well.

Biologics Outsourcing Market: Regional Landscape

the presence of a developed healthcare infrastructure the Biologics Outsourcing market in North America is expected to hold a dominant outlook over the forecast period. Increasing investments on research and development activities in North America is expected to be a prominent driver through 2028. Rising support from the government, increasing adoption of technology in healthcare, favorable reimbursement initiatives, and increasing demand for quality diagnostics and treatment are other factors that will drive the Biologics Outsourcing market growth over the forecast period. The United States is anticipated to be the most lucrative country in this region through 2028. Europe is anticipated to follow North America and be the second largest market for Biologics Outsourcing in the global landscape. Increasing research and development activities will also favor Biologics Outsourcing market growth through 2028.

The Asia Pacific is anticipated to be the fastest-growing Biologics Outsourcing market in the global Biologics Outsourcing industry landscape over the forecast period.

Biologics Outsourcing Market: Competitive Landscape

Some of the main competitors dominating the global Biologics Outsourcing market include – Catalent, Inc., Lonza Group AG, Wuxi Biologics, Boehringer Ingelheim, Abzena Limited, GL Biochem Corporation

Global Biologics Outsourcing market is segmented as follows:

By Type

  • Antibodies
  • Monoclonal Antibodies
  • Antibody Drug Conjugates
  • Recombinant Proteins
  • Vaccines
  • Others

By Source

  • Human
  • Microbial
  • Others

By Application

  • Stem Cell Research
  • Vaccine Development
  • Tissue Related Products development
  • Others

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

Increasing investment in research and development and rising focus on healthcare are some major trends that guide Biologics Outsourcing market growth.

According to the Market Research report, the global Biologics Outsourcing market was worth about US$ 11,285.4 million in 2021 and is predicted to grow to around US$ 23620.6 million by 2028, with a compound annual growth rate (CAGR) of around 13.1 percent.

the presence of a developed healthcare infrastructure the Biologics Outsourcing market in North America is expected to hold a dominant outlook over the forecast period. Increasing spending on research and development activities in this region is expected to be a prominent driver through 2028.

Some of the main competitors dominating the global Biologics Outsourcing market include -- Catalent, Inc., Lonza Group AG, Wuxi Biologics, Boehringer Ingelheim, Abzena Limited, GL Biochem Corporation

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed